Additional file 1 of The efficacy and safety of prasugrel in acute coronary syndrome: a propensity-matched Korean cohort study focused on age and weight of patients

Sang Hyun Kim(St. Mary's Hospital), Hyo-Soo Kim(Seoul National University Hospital), Mahn-won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Chul Soo Park(Catholic University of Korea), Youngkeun Ahn(Chonnam National University Hospital), Kiyuk Chang, Jong-Min Lee(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Eun Ho Choo(St. Mary's Hospital), Min Chul Kim(Chonnam National University), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Jeehoon Kang(Seoul National University Hospital), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital)
Open MIND
January 1, 2025
10.6084/m9.figshare.30969408.v1
Cited by 0

Related Papers

Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
|The Lancet|2021|202
Effect of Coronary CTA on Chronic Total Occlusion Percutaneous Coronary Intervention
|JACC. Cardiovascular imaging|2021|98
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
|The Lancet|2025|86
Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention
|Heart|2014|79